Alkermes (ALKS) Debt to Equity (2011 - 2026)
Alkermes (ALKS) reported Debt to Equity of $0.86 for Q1 2026, up 285.76% quarter-over-quarter from $0.22 in Q3 2024.
Alkermes (ALKS) Debt to Equity (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 15 years of Debt to Equity data on file, last reported at $0.86 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.86, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $0.86 (changed N/A YoY), and the FY2023 annual result was $0.24, down 13.97% from the prior year.
- Debt to Equity rose to $0.86 in Q1 2026 per ALKS's latest filing, from $0.22 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.86 in Q1 2026 and troughed at $0.21 in Q3 2023.
- A 4-year average of $0.3 and a median of $0.26 in 2022 frame the typical range for Debt to Equity.
- On a YoY basis, Debt to Equity climbed as much as 6.02% in 2023 and fell as far as 23.73% in 2023.
- A 4-year view of Debt to Equity shows it stood at $0.28 in 2022, then declined by 13.97% to $0.24 in 2023, then retreated by 7.53% to $0.22 in 2024, then soared by 285.76% to $0.86 in 2026.
- Business Quant data shows ALKS's Debt to Equity at $0.86 in Q1 2026, $0.22 in Q3 2024, and $0.23 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.86 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.47 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.86 |
| Sep 30, 2024 | 0.22 |
| Jun 30, 2024 | 0.23 |
| Mar 31, 2024 | 0.23 |
| Dec 31, 2023 | 0.24 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.23 |
| Mar 31, 2023 | 0.29 |
| Dec 31, 2022 | 0.28 |
| Sep 30, 2022 | 0.28 |
| Jun 30, 2022 | 0.27 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | 0.27 |
| Sep 30, 2021 | 0.27 |
| Jun 30, 2021 | 0.27 |
| Mar 31, 2021 | 0.28 |
| Dec 31, 2020 | 0.26 |
| Sep 30, 2020 | 0.25 |
| Jun 30, 2020 | 0.26 |
| Mar 31, 2020 | 0.26 |